Literature DB >> 25277434

Clinical use of deslorelin (GnRH agonist) in companion animals: a review.

X Lucas1.   

Abstract

Over the years, many contraceptive medications have been developed for companion animals, but many secondary adverse effects have limited their use. A major advancement was achieved with the use of gonadotropin-releasing hormone (GnRH) analogues, mainly GnRH agonists, which mimic the effects of native GnRH. The development of effective low-dose, slow-release implants with potent agonists such as deslorelin (Suprelorin®, Virbac) have allowed their use to become widespread in recent years, with many potential benefits in companion animals. While the major application of deslorelin was initially male contraception, due to its two differing actions, either the stimulation of oestrus or the sterilization of fertility, its use has been increasing in the bitch as well. The aim of this study is to review the applications of deslorelin GnRH agonist implants in companion animal, such as dogs, cats and some exotic pets.
© 2014 Blackwell Verlag GmbH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25277434     DOI: 10.1111/rda.12388

Source DB:  PubMed          Journal:  Reprod Domest Anim        ISSN: 0936-6768            Impact factor:   2.005


  7 in total

Review 1.  Infertility in Men: Advances towards a Comprehensive and Integrative Strategy for Precision Theranostics.

Authors:  Mourad Assidi
Journal:  Cells       Date:  2022-05-22       Impact factor: 7.666

2.  Immunocontraception of male and female giraffes using the GnRH vaccine Improvac®.

Authors:  Franz Schwarzenberger; Pia Krawinkel; Sophia-Maria Jeserschek; Nicole Schauerte; Christina Geiger; Folko Balfanz; Tobias Knauf-Witzens; Florian Sicks; Eva Martinez Nevado; Gwendoline Anfray; Anna Hein; Christine Kaandorp-Huber; Sandra Marcordes; Betina Venshøj
Journal:  Zoo Biol       Date:  2021-09-03       Impact factor: 1.495

3.  Length of efficacy and effect of implant location in adult tom cats treated with a 9.4 mg deslorelin subcutaneous implant.

Authors:  Stefano Romagnoli; Anna Baldan; Silvia Ferro; Camilla Righetti; Ludovico Scenna; Gianfranco Gabai; Tamara Badon; Christelle Fontaine; Antonio Mollo; Calogero Stelletta; Chiara Milani
Journal:  J Feline Med Surg       Date:  2018-07-30       Impact factor: 2.015

4.  Inactivated Rabies Virus-Vectored Immunocontraceptive Vaccine in a Thermo-Responsive Hydrogel Induces High and Persistent Antibodies against Rabies, but Insufficient Antibodies against Gonadotropin-Releasing Hormone for Contraception.

Authors:  Xianfu Wu; Yong Yang; Chantal Kling; Laurie Seigler; Nadia F Gallardo-Romero; Brock E Martin; Todd G Smith; Victoria A Olson
Journal:  Vaccines (Basel)       Date:  2019-07-25

Review 5.  Some of the Factors Involved in Male Infertility: A Prospective Review.

Authors:  Emad Babakhanzadeh; Majid Nazari; Sina Ghasemifar; Ali Khodadadian
Journal:  Int J Gen Med       Date:  2020-02-05

Review 6.  Therapeutic peptides: current applications and future directions.

Authors:  Lei Wang; Nanxi Wang; Wenping Zhang; Xurui Cheng; Zhibin Yan; Gang Shao; Xi Wang; Rui Wang; Caiyun Fu
Journal:  Signal Transduct Target Ther       Date:  2022-02-14

7.  Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone.

Authors:  Sanjay K Agarwal; AnnaMarie Daniels; Steven R Drosman; Laurence Udoff; Warren G Foster; Malcolm C Pike; Darcy V Spicer; John R Daniels
Journal:  Biomed Res Int       Date:  2015-12-31       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.